Links Production TEVA PRODUCTS PRESS RELEASES SOCIAL COMMITMENT INITIATIVES CONTACTS Home Products Biosimilar drugs Definition DEFINITION DEFINITION Biotechnologies have made it possible to develop highly effective and targeted treatments for many serious diseases. Biological drugs, produced with biotechnology, have already contributed to the treatment of millions of patients with diseases such as cancer, multiple sclerosis, diabetes, rheumatoid arthritis and other autoimmune and rare diseases. The first biologics were approved in the 1980s. For some patents or exclusive rights have already expired, for many others they will expire in the next few years. In light of the patent deadlines, biological drugs similar to those with expired coverage, commonly referred to as biosimilars, are already on the market - and more will arrive soon. The biosimilar drug, therefore, is nothing more than a drug comparable to a biological drug already authorized and whose patent has expired. The marketing authorization of a biosimilar drug is based on a procedure aimed at verifying its comparability with the product or reference, in terms of quality, safety and efficacy. TEVA Teva in the world Teva in Italy Culture and values Model pursuant to Legislative Decree 231/2001 Supplier Code of Conduct Responsible transparency PRODUCTS Teva quality Equivalent drugs Biosimilar drugs Self-medication Specialized and innovative drugs Production Package leaflets PRESS RELEASES 2018 2017 2016 2015 2014 2013 2012 SOCIAL COMMITMENT Grants and Scholarships Therapeutic adherence Social responsability Sport and Health INITIATIVES Yourteva App InSalute Tour 2018 DiaDay 2017 campaign Panorama of Italy 2017 Health Innovation Award 2017 Health time 2017 Multiple Sclerosis and Pregnancy PRODUCTION Active pharmaceutical ingredients Finished products TEVA ITALIA S.R.L. Sede Legale: Piazzale Luigi Cadorna, n. 4 - 20123 Milano Sede Amministrativa e uffici: viale del Mulino, 1 pal. U10 - centro direzionale Milanofiori Nord 20090 Assago (Mi) Società con unico Socio Capitale Sociale Euro 1.460.000 iv (interamente versato) Codice Fiscale e Partita IVA N. 11654150157 Registro Imprese di Milano N. 11654150157 DISCLAIMER E NOTE LEGALI COOKIE POLICY PRIVACY POLICY FARMACOVIGILANZA PRIVACY POLICY TERMINI DI UTILIZZO SOCIAL COMUNICARE CON TEVA We use cookies to ensure the functionality of the site and to take into account the user's browsing preferences, in order to offer the best browsing experience on the site. We also reserve the right to use third-party cookies. For more information, you can consult the Privacy Policy and Cookie Policy . By continuing to browse the site, you agree to use cookies. X